Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    ... side effects, and the safety of increasing doses of lenalidomide in patients with AML and MDS who have a small amount of ... Associated Drug(s):  Lenalidomide Phase:  Phase 1 ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.

  2. Pregnancy in Bone Marrow Failure Disease

    ... outcomes are also improved with this drug. Use of lenalidomide (Revlimid®) during pregnancy is known to be harmful because ... Does this mean only other drug therapies can be used? Lenalidomide is a derivative medication of the drug thalidomide . In the ...

    Interview last updated 01/13/2017 - 9:28am.

  3. MDS Drug Therapy

    ... and high-risk patients with all sub-types of MDS Lenalidomide (Revlimid®) for transfusion-dependent MDS patients with ... Lenalidomide (Revlimid®) Lenalidomide ...

    Topic section last updated 03/10/2016 - 11:26pm.

  4. MEDALIST Trial

    ... MDS disease (eg, immune-modulatory drug [IMiDs such as lenalidomide ], hypomethylating agents, or immunosuppressive therapy [IST]). ...

    Clinical Trial last updated 02/22/2017 - 11:42am.

  5. MDS and Inflammation

    ... (AML). His pioneering work led to the development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which ...

    Interview last updated 02/14/2017 - 8:52am.

  6. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... failed to respond to or progressed on treatment with lenalidomide j. Eastern Cooperative Oncology Group (ECOG) performance ... Treatment with cytarabine at any dose, lenalidomide , or any other therapy targeted for the treatment of MDS (other ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  7. San Diego Family Takes Action for Awareness

    ... drugs, azacitidine , decitabine , and lenalidomide – noting of course that the latter was on for the 5q ...

    Patient Chronicle last updated 10/26/2016 - 11:42am.

  8. More is better: Combination therapies for myelodysplastic syndromes

    ... are currently three FDA-approved medications for MDS: lenalidomide , azacitidine , and decitabine .  Although these ... and acceptable side-effect profiles. -Azacitidine and lenalidomide, two FDA approved drugs in MDS, have also been combined with ...

    Research Review last updated 05/02/2016 - 9:14am.

  9. New therapeutics for myelodysplastic syndromes

    ... with myelodysplastic syndromes (MDS), including lenalidomide (Revlimidâ) and the azanucleosides, azacitidine ... Efforts are also underway to improve the effectiveness of lenalidomide, a drug with preferential activity in the group of MDS patients ...

    Research Review last updated 05/02/2016 - 9:28am.

  10. Recent developments in myelodysplastic syndromes

    ... – 2006 ( azacitidine , decitabine , and lenalidomide ), none of these are curative.  In addition, no new drugs have ... with chromosome 5q deletions are more likely to respond to lenalidomide. -High-resolution genome-wide techniques can detect ...

    Research Review last updated 05/02/2016 - 9:16am.